New Definition of Obesity Led to Increased Prevalence of Obesity
Prevalence increased to 68.6 percent with new criteria, which include anthropometric measures such as waist circumference, waist-to-hip ratio, waist-to-height ratio
Stronger Grip Strength Protects Against Obesity-Related Outcomes
Authors say findings underscore the importance of improving muscle mass and strength in at-risk people
New Diagnosis Code Added for Patients With Type 2 Diabetes in Remission
New ICD-10 diagnosis code is for patients with history of type 2 diabetes who bring blood sugar levels to a non-diabetic range below 6.5% for at least three months
ACS: 2020 to 2024 Saw Jump in Use of GLP-1 Receptor Agonists Before Metabolic,...
Even higher use seen in patients without type 2 diabetes
Rates of Physician Attrition From Clinical Practice Have Risen Since 2013
Rates of attrition up for male and female physicians, in rural and urban settings, across specialties, across geographic regions
Continuous Glucose Monitors Not Accurate in People Without Diabetes
Authors say in those without diabetes, continuous glucose monitors are not a substitute for HbA1c
Weight-Loss Treatment Tied to Lower Risk for Obesity-Related Cancers
Findings seen for both medication and surgical procedures in people with obesity and type 2 diabetes
12.4 Percent of Older Adults Have Ultraprocessed Food Addiction
Men and women reporting overweight, respectively, are 19.14 and 11.44 times more likely to meet criteria for UPF addiction
Costco to Sell Ozempic and Wegovy for $499 a Month
The same price is already available on Novo Nordisk’s direct-to-consumer website, as well as at Walmart and CVS
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
Findings seen for long-term outcomes among adult patients with diabetes and obesity
